These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29482177)

  • 1. Evaluation on the effects of 0.1% Peumus boldus leaf and Spiraea ulmaria plant extract combination on bacterial colonization in canine atopic dermatitis: A preliminary randomized, placebo controlled, double-blinded study.
    Santoro D; Bohannon M; Ahrens K; Navarro C; Gatto H; Marsella R
    Res Vet Sci; 2018 Jun; 118():164-170. PubMed ID: 29482177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the secretion of antimicrobial peptides and antimicrobial effect of skin wash in atopic and healthy dogs: a preliminary study.
    Santoro D
    Vet Dermatol; 2018 Oct; 29(5):402-e132. PubMed ID: 29963726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of canine atopic dermatitis using the plant extract PYM00217: a randomized, double-blind, placebo-controlled clinical study.
    Ferguson EA; Littlewood JD; Carlotti DN; Grover R; Nuttall T
    Vet Dermatol; 2006 Aug; 17(4):236-43. PubMed ID: 16827666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of canine antimicrobial peptides in infected and noninfected chronic atopic skin.
    Santoro D; Bunick D; Graves TK; Segre M
    Vet Dermatol; 2013 Feb; 24(1):39-47.e10. PubMed ID: 23331678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The glucocorticoid sparing efficacy of Phytopica in the management of canine atopic dermatitis.
    Schmidt V; McEwan N; Volk A; Helps J; Morrell K; Nuttall T
    Vet Dermatol; 2010 Feb; 21(1):96-105. PubMed ID: 20187915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single blinded, randomized, placebo-controlled study on the effects of ciclosporin on cutaneous barrier function and immunological response in atopic beagles.
    White AG; Santoro D; Ahrens K; Marsella R
    Vet Immunol Immunopathol; 2018 Mar; 197():93-101. PubMed ID: 29475513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, placebo-controlled study to evaluate the effect of EFF1001, an Actinidia arguta (hardy kiwi) preparation, on CADESI score and pruritus in dogs with mild to moderate atopic dermatitis.
    Marsella R; Messinger L; Zabel S; Rosychuck R; Griffin C; Cronin PO; Belofsky G; Lindemann J; Stull D
    Vet Dermatol; 2010 Feb; 21(1):50-7. PubMed ID: 19843302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of a 0.0584% hydrocortisone aceponate spray in the management of canine atopic dermatitis: a randomised, double blind, placebo-controlled trial.
    Nuttall T; Mueller R; Bensignor E; Verde M; Noli C; Schmidt V; Rème C
    Vet Dermatol; 2009 Jun; 20(3):191-8. PubMed ID: 19374721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized, double-blinded, placebo-controlled pilot study on the effects of topical blackcurrant emulsion enriched in essential fatty acids, ceramides and 18-beta glycyrrhetinic acid on clinical signs and skin barrier function in dogs with atopic dermatitis.
    Marsella R; Cornegliani L; Ozmen I; Bohannon M; Ahrens K; Santoro D
    Vet Dermatol; 2017 Dec; 28(6):577-e140. PubMed ID: 28736984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of a topical lipid complex therapy on dogs with atopic dermatitis: a double blind, randomized, placebo-controlled study.
    Hobi S; Klinger C; Classen J; Mueller RS
    Vet Dermatol; 2017 Aug; 28(4):369-e84. PubMed ID: 28220545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A blinded, randomized, placebo-controlled, dose determination trial of lokivetmab (ZTS-00103289), a caninized, anti-canine IL-31 monoclonal antibody in client owned dogs with atopic dermatitis.
    Michels GM; Ramsey DS; Walsh KF; Martinon OM; Mahabir SP; Hoevers JD; Walters RR; Dunham SA
    Vet Dermatol; 2016 Dec; 27(6):478-e129. PubMed ID: 27647569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and distribution of canine antimicrobial peptides in the skin of healthy and atopic beagles.
    Santoro D; Marsella R; Bunick D; Graves TK; Campbell KL
    Vet Immunol Immunopathol; 2011 Dec; 144(3-4):382-8. PubMed ID: 21889803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A blinded, randomized, placebo-controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel®) in client-owned dogs with atopic dermatitis.
    Cosgrove SB; Wren JA; Cleaver DM; Walsh KF; Follis SI; King VI; Tena JK; Stegemann MR
    Vet Dermatol; 2013 Dec; 24(6):587-97, e141-2. PubMed ID: 24581322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of proactive long-term maintenance therapy of canine atopic dermatitis with 0.0584% hydrocortisone aceponate spray: a double-blind placebo controlled pilot study.
    Lourenço AM; Schmidt V; São Braz B; Nóbrega D; Nunes T; Duarte-Correia JH; Matias D; Maruhashi E; Rème CA; Nuttall T
    Vet Dermatol; 2016 Apr; 27(2):88-92e25. PubMed ID: 26804943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparable efficacy of a topical 0.0584% hydrocortisone aceponate spray and oral ciclosporin in treating canine atopic dermatitis.
    Nuttall TJ; McEwan NA; Bensignor E; Cornegliani L; Löwenstein C; Rème CA
    Vet Dermatol; 2012 Feb; 23(1):4-10, e1-2. PubMed ID: 21718368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D shows in vivo efficacy in a placebo-controlled, double-blinded, randomised clinical trial on canine atopic dermatitis.
    Klinger CJ; Hobi S; Johansen C; Koch HJ; Weber K; Mueller RS
    Vet Rec; 2018 Apr; 182(14):406. PubMed ID: 29419484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of 0.0584% hydrocortisone aceponate topical spray and systemic oclacitinib combination therapy in dogs with atopic dermatitis: a randomized, double-blinded, placebo-controlled trial.
    Takahashi J; Kanda S; Imanishi I; Hisano T; Fukamachi T; Taguchi N; Momiyama S; Nishiyama S; Motegi T; Iyori K
    Vet Dermatol; 2021 Apr; 32(2):119-e25. PubMed ID: 33185330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs.
    Little PR; King VL; Davis KR; Cosgrove SB; Stegemann MR
    Vet Dermatol; 2015 Feb; 26(1):23-30, e7-8. PubMed ID: 25496303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation on the clinical efficacy and safety of 0.1% tacrolimus ointment (Protopic) in canine atopic dermatitis: a randomized, double-blinded, placebo-controlled, cross-over study.
    Marsella R; Nicklin CF; Saglio S; Lopez J
    Vet Dermatol; 2004 Oct; 15(5):294-303. PubMed ID: 15500481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of a spot-on formulation containing polyunsaturated fatty acids and essential oils on dogs with atopic dermatitis.
    Blaskovic M; Rosenkrantz W; Neuber A; Sauter-Louis C; Mueller RS
    Vet J; 2014 Jan; 199(1):39-43. PubMed ID: 24355814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.